Leucocytoclastic vasculitis and indinavir [12]

British Journal of Dermatology

Volumn 143, Issue 5, 2000, Pages 1112-1113

  Rachline, A ^a   Lariven, S ^a   Descamps, V ^a   Grossin, M ^a   Bouvet, E ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ETHAMBUTOL; INDINAVIR; ISONIAZID; LAMIVUDINE; OFLOXACIN; PYRAZINAMIDE; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ADULT; ALOPECIA; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LEUKOCYTOCLASTIC VASCULITIS; LIPODYSTROPHY; MALE; PARONYCHIA; PRIORITY JOURNAL; TUBERCULOUS LYMPHADENITIS; UROLITHIASIS;

ADULT; DRUG ERUPTIONS; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; MALE; VASCULITIS, HYPERSENSITIVITY;

EID: 0033730540     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03870.x     Document Type: Letter

References (5)

1. HIV-related vasculitis: Clinical presentation and therapeutic approach on six patients
2. The spectrum of vasculitis in human immunodeficiency virus-infected patients
3. Adverse drug reaction monitoring: Doing it the French way
4. Zidovudine-induced leukocytoclastic vasculitis
5. Cutaneous vasculitis associated with didanosine